Focused Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Focused Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$1	–	1169
2022 Q4	$1	Buy	+5,000	New	+$6.63K	﹤0.01%	1089
2022 Q3	–	Sell	-5,000	Closed	-$1K	–	1101
2022 Q2	$1K	Hold	5,000	–	–	﹤0.01%	904
2022 Q1	$1K	Hold	5,000	–	–	﹤0.01%	967
2021 Q4	$4K	Hold	5,000	–	–	﹤0.01%	743
2021 Q3	$12K	Buy	+5,000	New	+$42.4K	﹤0.01%	578

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

OAJ

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Focused Wealth Management's SRNE Position: Q2 2023 in Review

Focused Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 6,000 shares — an estimated $2.16K sold.

Focused Wealth Management first reported a position in SRNE in Q4 2019 and held it in 14 quarters. The position peaked at $134K in Q3 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

Focused Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
Focused Wealth Management sold 6,000 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $2.16K.
Focused Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2019 and held it in 14 quarters.
Focused Wealth Management's Sorrento Therapeutics, Inc. position peaked at $134K in Q3 2020.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Focused Wealth Management's 13F filing for Q2 2023, filed 8 Aug 2023.